Earlier this week, the U.S. Department of Justice announced that a medical practice in Greenville, South Carolina pled guilty in federal court to purchasing BOTOX® from a foreign and unauthorized supplier (see link to press release below).  Records obtained during the investigation showed that, from 2010-2013, the medical practice purchased non-FDA approved BOTOX® from a foreign wholesaler.  This BOTOX® was deemed misbranded under federal law as it was not FDA-approved for sale in the United States.  The medical practice was placed on 3 years of federal probation and it agreed to pay $300,000 to the United States in a parallel civil case brought by the U.S. Attorney’s Office.

This case again highlights the risks to doctors and medical practices of purchasing BOTOX®, BOTOX® Cosmetic and other prescription products from unauthorized suppliers, including Amazon Medica.  In addition to placing doctors and their medical license at risk, the purchase of prescription drugs from foreign and unlicensed suppliers also poses a significant risk to patients.  Please refer customers to our approved illegal importation materials and/or www.authenticbotoxcosmetic.com where appropriate

Read more about this story here. 

AuthorOscar Bueno